Director, Agentic AI Platform, China
About the Beijing AI Center The Beijing AI Center is a new strategic investment by AstraZeneca to accelerate drug discovery through AI. The center brings together AI researchers, computational scientists, and platform engineers to apply foundation models, agentic AI, and large-scale scientific computing to real R&D problems. Situated in one of the world’s most dynamic AI talent markets, it operates at the intersection of biologics discovery, computational chemistry, and...
- Lean
- Agile
- Scrum
- Product Management